TP53BP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.247200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.459600E-01
Normal-vs-Stage2
9.879000E-01
Normal-vs-Stage3
2.847400E-01
Normal-vs-Stage4
5.046200E-01
Stage1-vs-Stage2
3.238800E-01
Stage1-vs-Stage3
1.101810E-01
Stage1-vs-Stage4
9.272200E-01
Stage2-vs-Stage3
1.260850E-01
Stage2-vs-Stage4
3.506400E-01
Stage3-vs-Stage4
1.365440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.912400E-01
Normal-vs-AfricanAmerican
9.704600E-01
Normal-vs-Asian
7.654400E-01
Caucasian-vs-AfricanAmerican
8.142800E-01
Caucasian-vs-Asian
3.975200E-01
AfricanAmerican-vs-Asian
7.239600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.610200E-01
Normal-vs-Female
8.755200E-01
Male-vs-Female
6.485000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.484600E-01
Normal-vs-Age(41-60Yrs)
4.815000E-01
Normal-vs-Age(61-80Yrs)
8.509600E-01
Normal-vs-Age(81-100Yrs)
2.409000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.679000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.289800E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.383900E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.518900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.610800E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.119190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.856000E-01
Normal-vs-Daily Drinker
9.922000E-01
Normal-vs-Weekly Drinker
6.650800E-01
Normal-vs-Occasional Drinker
4.823000E-01
Normal-vs-Social Drinker
6.596000E-01
Non Drinker-vs-Daily Drinker
5.634800E-01
Non Drinker-vs-Weekly Drinker
8.448600E-01
Non Drinker-vs-Occasional Drinker
3.912200E-02
Non Drinker-vs-Social Drinker
1.665170E-01
Daily Drinker-vs-Weekly Drinker
4.677600E-01
Daily Drinker-vs-Occasional Drinker
1.149760E-01
Daily Drinker-vs-Social Drinker
3.536600E-01
Weekly Drinker-vs-Occasional Drinker
6.189600E-02
Weekly Drinker-vs-Social Drinker
1.690170E-01
Occasional Drinker-vs-Social Drinker
5.769400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.042820E-01
Normal-vs-Grade 2
4.116600E-03
Normal-vs-Grade 3
7.858700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.759000E-01
Grade 1-vs-Grade 3
3.805200E-01
Grade 1-vs-Grade 4
1.042820E-01
Grade 2-vs-Grade 3
8.709500E-02
Grade 2-vs-Grade 4
4.116600E-03
Grade 3-vs-Grade 4
7.858700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.139200E-01
Normal-vs-NonDiabetic
8.300400E-01
Diabetic-vs-NonDiabetic
1.015400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.789600E-01
Normal-vs-NoPancreatitis
9.339400E-01
Pancreatitis-vs-NoPancreatitis
3.127200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.669400E-01
Normal-vs-N1
9.680200E-01
N0-vs-N1
6.195600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.537600E-01
Normal-vs-TP53-NonMutant
9.337200E-01
TP53-Mutant-vs-TP53-NonMutant
3.918600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
